Payment overview · 2025
General Payments
$20.08
1 reported records · 1 companies
Healthcare provider profile · identity verified
Brian Neely, MD
Allopathic & Osteopathic Physicians|Family Medicine · IOLA, KS · NPI 1851654420
Verified facts
What the public records show
CMS Open Payments records show Brian Neely, MD received $20.08 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 35 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $20.08 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $20.08 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $20.08 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 37 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
35 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
37 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
21 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 784 | 199 |
| Levothyroxine Sodium | Levothyroxine Sodium | 605 | 130 |
| Amlodipine Besylate | Amlodipine Besylate | 592 | 162 |
| Lisinopril | Lisinopril | 523 | 150 |
| Pantoprazole Sodium | Pantoprazole Sodium | 482 | 106 |
| Furosemide | Furosemide | 430 | 93 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 423 | 71 |
| Potassium Chloride | Potassium Chloride | 366 | 83 |
| Sertraline Hcl | Sertraline Hcl | 347 | 75 |
| Gabapentin | Gabapentin | 330 | 63 |
| Omeprazole | Omeprazole | 320 | 93 |
| Losartan Potassium | Losartan Potassium | 297 | 82 |
| Eliquis | Apixaban | 292 | 40 |
| Simvastatin | Simvastatin | 279 | 63 |
| Tamsulosin Hcl | Tamsulosin Hcl | 257 | 57 |
| Meloxicam | Meloxicam | 242 | 64 |
| Carvedilol | Carvedilol | 231 | 52 |
| Metformin Hcl | Metformin Hcl | 226 | 67 |
| Tramadol Hcl | Tramadol Hcl | 215 | 47 |
| Duloxetine Hcl | Duloxetine Hcl | 212 | 43 |
| Alprazolam | Alprazolam | 210 | 52 |
| Trazodone Hcl | Trazodone Hcl | 193 | 35 |
| Pregabalin | Pregabalin | 192 | 40 |
| Montelukast Sodium | Montelukast Sodium | 176 | 54 |
| Metformin Hcl Er | Metformin Hcl | 174 | 40 |
| Tizanidine Hcl | Tizanidine Hcl | 171 | 52 |
| Metoprolol Succinate | Metoprolol Succinate | 168 | 52 |
| Prednisone | Prednisone | 166 | 99 |
| Warfarin Sodium | Warfarin Sodium | 163 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 152 | 35 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 150 | 53 |
| Celecoxib | Celecoxib | 147 | 51 |
| Allopurinol | Allopurinol | 134 | 31 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 131 | 33 |
| Alendronate Sodium | Alendronate Sodium | 127 | 35 |
| Fluoxetine Hcl | Fluoxetine Hcl | 125 | 27 |
| Clonazepam | Clonazepam | 122 | 19 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 121 | 24 |
| Bumetanide | Bumetanide | 119 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 119 | 29 |
| Oxycodone Hcl | Oxycodone Hcl | 119 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 117 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 111 | 39 |
| Morphine Sulfate Er | Morphine Sulfate | 102 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 101 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 101 | 39 |
| Pravastatin Sodium | Pravastatin Sodium | 95 | 25 |
| Buspirone Hcl | Buspirone Hcl | 94 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 90 | 30 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 90 | 25 |
| Myrbetriq | Mirabegron | 87 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 83 | 60 |
| Propranolol Hcl | Propranolol Hcl | 83 | 18 |
| Ozempic | Semaglutide | 80 | 16 |
| Jardiance | Empagliflozin | 79 | 17 |
| Spironolactone | Spironolactone | 79 | 20 |
| Mirtazapine | Mirtazapine | 74 | 16 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 73 | 25 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 64 | 55 |
| Famotidine | Famotidine | 64 | 19 |
| Donepezil Hcl | Donepezil Hcl | 63 | 14 |
| Estradiol | Estradiol | 63 | 18 |
| Sucralfate | Sucralfate | 63 | 13 |
| Bupropion Xl | Bupropion Hcl | 62 | 17 |
| Finasteride | Finasteride | 62 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 61 | 52 |
| Bupropion Hcl Sr | Bupropion Hcl | 60 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 60 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 60 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 57 | 14 |
| Naproxen | Naproxen | 56 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 56 | 13 |
| Digoxin | Digoxin | 54 | 13 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 54 | 11 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 52 | suppressed |
| Baclofen | Baclofen | 51 | suppressed |
| Azithromycin | Azithromycin | 50 | 43 |
| Tresiba Flextouch U-200 | Insulin Degludec | 50 | 18 |
| Zolpidem Tartrate | Zolpidem Tartrate | 50 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 48 | 38 |
| Ezetimibe | Ezetimibe | 47 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 47 | 14 |
| Lorazepam | Lorazepam | 47 | suppressed |
| Synthroid | Levothyroxine Sodium | 47 | 13 |
| Xarelto | Rivaroxaban | 47 | suppressed |
| Atenolol | Atenolol | 46 | suppressed |
| Januvia | Sitagliptin Phosphate | 44 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 23 |
| Lactulose | Lactulose | 43 | 21 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 42 | suppressed |
| Diazepam | Diazepam | 42 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 42 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 41 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 41 | 12 |
| Glimepiride | Glimepiride | 41 | 14 |
| Nifedipine Er | Nifedipine | 40 | 11 |
| Torsemide | Torsemide | 40 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 40 | 13 |
| Mounjaro | Tirzepatide | 39 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 38 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 38 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 37 | suppressed |
| Fentanyl | Fentanyl | 36 | suppressed |
| Brilinta | Ticagrelor | 35 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 35 | suppressed |
| Chlorthalidone | Chlorthalidone | 35 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 35 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 35 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 34 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 32 | 11 |
| Benazepril Hcl | Benazepril Hcl | 31 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 30 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 30 | suppressed |
| Telmisartan | Telmisartan | 30 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Nystatin | Nystatin | 29 | 17 |
| Cephalexin | Cephalexin | 28 | suppressed |
| Lovastatin | Lovastatin | 28 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 26 | suppressed |
| Lamotrigine | Lamotrigine | 25 | suppressed |
| Linzess | Linaclotide | 25 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 25 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 25 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Trulicity | Dulaglutide | 25 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Vascepa | Icosapent Ethyl | 24 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 23 | suppressed |
| Novolog Flexpen | Insulin Aspart | 23 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | 11 |
| Cilostazol | Cilostazol | 22 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 22 | suppressed |
| Ketoconazole | Ketoconazole | 21 | 13 |
| Levetiracetam | Levetiracetam | 21 | suppressed |
| Mupirocin | Mupirocin | 21 | 14 |
| Nebivolol Hcl | Nebivolol Hcl | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 21 | suppressed |
| Acitretin | Acitretin | 20 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | 15 |
| Ofloxacin | Ofloxacin | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 20 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Glipizide | Glipizide | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Constulose | Lactulose | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Temazepam | Temazepam | 18 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 18 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 17 | suppressed |
| Humulin R | Insulin Regular, Human | 17 | suppressed |
| Metronidazole | Metronidazole | 17 | 11 |
| Amoxicillin | Amoxicillin | 16 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Gemfibrozil | Gemfibrozil | 16 | suppressed |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine Dimesylate | 16 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 16 | 14 |
| Irbesartan | Irbesartan | 15 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 15 | suppressed |
| Amantadine | Amantadine Hcl | 14 | suppressed |
| Ibuprofen | Ibuprofen | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Methadone Hcl | Methadone Hcl | 13 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 13 | 12 |
| Primidone | Primidone | 13 | suppressed |
| Admelog Solostar | Insulin Lispro | 12 | suppressed |
| Azathioprine | Azathioprine | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 12 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Loperamide | Loperamide Hcl | 12 | suppressed |
| Modafinil | Modafinil | 12 | suppressed |
| Multaq | Dronedarone Hcl | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Fluorometholone | Fluorometholone | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 11 | suppressed |
| Verapamil Sr | Verapamil Hcl | 11 | suppressed |
| Vraylar | Cariprazine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $20.08 · 1 records | AstraZeneca Pharmaceuticals LP | FARXIGA | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error